| Comprehensive molecular characterization of papillary renal-cell carcinoma Cancer Genome Atlas Research Network New England Journal of Medicine 374 (2), 135-145, 2016 | 1198 | 2016 |
| Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures Y Şenbabaoğlu, RS Gejman, AG Winer, M Liu, EM Van Allen, ... Genome biology 17, 1-25, 2016 | 790 | 2016 |
| Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma E Wurmbach, Y Chen, G Khitrov, W Zhang, S Roayaie, M Schwartz, I Fiel, ... Hepatology 45 (4), 938-947, 2007 | 734 | 2007 |
| An integrated metabolic atlas of clear cell renal cell carcinoma AA Hakimi, ED Reznik, CH Lee, CJ Creighton, AR Brannon, A Luna, ... Cancer cell 29 (1), 104-116, 2016 | 667 | 2016 |
| Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma N Palanisamy, B Ateeq, S Kalyana-Sundaram, D Pflueger, ... Nature medicine 16 (7), 793-798, 2010 | 554 | 2010 |
| A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis JM Llovet, Y Chen, E Wurmbach, S Roayaie, MI Fiel, M Schwartz, ... Gastroenterology 131 (6), 1758-1767, 2006 | 464 | 2006 |
| Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network AA Hakimi, I Ostrovnaya, B Reva, N Schultz, YB Chen, M Gonen, H Liu, ... Clinical Cancer Research 19 (12), 3259-3267, 2013 | 385 | 2013 |
| Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase KN Alavian, H Li, L Collis, L Bonanni, L Zeng, S Sacchetti, E Lazrove, ... Nature cell biology 13 (10), 1224-1233, 2011 | 320 | 2011 |
| Hereditary leiomyomatosis and renal cell carcinoma syndrome–associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant … YB Chen, AR Brannon, A Toubaji, ME Dudas, HH Won, HA Al-Ahmadie, ... The American journal of surgical pathology 38 (5), 627-637, 2014 | 263 | 2014 |
| Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma AA Hakimi, YB Chen, J Wren, M Gonen, O Abdel-Wahab, A Heguy, H Liu, ... European urology 63 (5), 848-854, 2013 | 263 | 2013 |
| Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neurons H Li, Y Chen, AF Jones, RH Sanger, LP Collis, R Flannery, EC McNay, ... Proceedings of the National Academy of Sciences 105 (6), 2169-2174, 2008 | 260 | 2008 |
| Bcl-xL increases mitochondrial fission, fusion, and biomass in neurons SB Berman, Y Chen, B Qi, JM McCaffery, EB Rucker III, S Goebbels, ... Journal of Cell Biology 184 (5), 707-719, 2009 | 247 | 2009 |
| Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential Y Chen, MA Aon, YT Hsu, L Soane, X Teng, JM McCaffery, WC Cheng, ... Journal of Cell Biology 195 (2), 263-276, 2011 | 231 | 2011 |
| Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy C Krishna, RG DiNatale, F Kuo, RM Srivastava, L Vuong, D Chowell, ... Cancer cell 39 (5), 662-677. e6, 2021 | 225 | 2021 |
| Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy MH Voss, AA Hakimi, CG Pham, AR Brannon, YB Chen, LF Cunha, ... Clinical cancer research 20 (7), 1955-1964, 2014 | 223 | 2014 |
| Genomic biomarkers of a randomized trial comparing first-line everolimus and sunitinib in patients with metastatic renal cell carcinoma JJ Hsieh, D Chen, PI Wang, M Marker, A Redzematovic, YB Chen, ... European urology 71 (3), 405-414, 2017 | 209 | 2017 |
| Transcriptomic profiling of the tumor microenvironment reveals distinct subgroups of clear cell renal cell cancer: data from a randomized phase III trial AA Hakimi, MH Voss, F Kuo, A Sanchez, M Liu, BG Nixon, L Vuong, ... Cancer discovery 9 (4), 510-525, 2019 | 202 | 2019 |
| New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia K Trpkov, O Hes, SR Williamson, AJ Adeniran, A Agaimy, ... Modern Pathology 34 (7), 1392-1424, 2021 | 193 | 2021 |
| Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer HA Al-Ahmadie, G Iyer, BH Lee, SN Scott, R Mehra, A Bagrodia, ... Nature genetics 48 (4), 356-358, 2016 | 183 | 2016 |
| Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets YB Chen, J Xu, AJ Skanderup, Y Dong, AR Brannon, L Wang, HH Won, ... Nature communications 7 (1), 13131, 2016 | 171 | 2016 |
